You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CCR5 antagonist

Showing 1 - 25 of 6,170
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC), Pancreatic Ductal Adenocarcinoma Trial in Baltimore (Stereotactic Body

Recruiting
  • Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)
  • Pancreatic Ductal Adenocarcinoma
  • Stereotactic Body Radiation (SBRT)
  • +3 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Jan 28, 2022

HIV Trial in Puerto Rico, United States (Vicriviroc)

Completed
Has Results
  • HIV Infections
  • San Diego, California
  • +8 more
Nov 3, 2021

Hematologic Malignancy Trial in Philadelphia (Maraviroc 300 mg)

Completed
Has Results
  • Hematologic Malignancy
  • Maraviroc 300 mg
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Dec 16, 2020

Rectal Cancer Trial in Frankfurt (drug, radiation, procedure)

Recruiting
  • Rectal Cancer
  • Kineret 100 MG in 0.67 ML Prefilled Syringe
  • +3 more
  • Frankfurt, Germany
    University Hospital Goethe University Frankfurt
Aug 23, 2022

CCR5, Microsatellite Stable, Metastatic Trial (700mg leronlimab weekly dose, 80mg Regorafenib at week 1, 120mg Regorafenib at

Withdrawn
  • CCR5
  • +3 more
  • 700mg leronlimab weekly dose
  • +3 more
  • (no location specified)
Feb 15, 2023

HIV Trial in Puerto Rico, United States (PRO 140, Placebo, Optimized Background Regimen)

Completed
  • HIV
  • PRO 140
  • +2 more
  • Fountain Valley, California
  • +36 more
Sep 28, 2021

COVID-19, SARS-CoV2 Infection Trial in India (Candesartan Cilexetil, Repagermanium, Candesartan Placebo)

Recruiting
  • COVID-19
  • SARS-CoV2 Infection
  • Candesartan Cilexetil
  • +3 more
  • Guntur, India
  • +4 more
Mar 13, 2022

Solid Tumor, Adult Trial in San Francisco (Leronlimab)

Active, not recruiting
  • Solid Tumor, Adult
  • San Francisco, California
    Quest Clinical Research
Jun 30, 2022

Triple Negative Breast Tumors Trial in San Francisco, Chicago (350 mg leronlimab, 525 mg leronlimab, 700 mg leronlimab)

Active, not recruiting
  • Triple Negative Breast Neoplasms
  • 350 mg leronlimab
  • +4 more
  • San Francisco, California
  • +1 more
Mar 18, 2022

LARS - Low Anterior Resection Syndrome Trial in Seoul (Ramosetron)

Not yet recruiting
  • LARS - Low Anterior Resection Syndrome
  • Seoul, Jongro-gu, Korea, Republic of
    Seoul National University Hospital
Dec 13, 2022

Metastatic Colorectal Cancer, MSS Trial in Heidelberg (Pembrolizumab, Maraviroc)

Completed
Has Results
  • Metastatic Colorectal Cancer
  • MSS
  • Heidelberg, Germany
    National Center for Tumor Diseases, University Hospital Heidelbe
May 17, 2022

Prostatic Hyperplasia, Prostate Cancer Trial in Turku (Prostate hyperplasia medication, LhRH-antagonist)

Recruiting
  • Prostatic Hyperplasia
  • Prostate Cancer
  • Turku, Finland
  • +1 more
Aug 17, 2023

HIV Trial in Cincinnati (SB-728-T, Expanded unmodified autologous CD4+ T cells)

Active, not recruiting
  • HIV Infections
  • SB-728-T
  • Expanded unmodified autologous CD4+ T cells
  • Cincinnati, Ohio
    University of Cincinnati
Jan 1, 2022

Metastatic Triple-Negative Breast Carcinoma Trial (Leronlimab)

No longer available
  • Metastatic Triple-Negative Breast Carcinoma
  • (no location specified)
Jan 13, 2022

HIV Trial in United States (SB-728mR-HSPC Infusion 3 days following busulfan conditioning)

Active, not recruiting
  • HIV
  • SB-728mR-HSPC Infusion 3 days following busulfan conditioning
  • Duarte, California
  • +4 more
Mar 7, 2022

Acute Respiratory Distress Syndrome Trial in Montréal (Placebo, Ondansetron Injection)

Not yet recruiting
  • Acute Respiratory Distress Syndrome
  • Placebo
  • Ondansetron Injection
  • Montréal, Quebec, Canada
    Hôpital Sacré-Coeur de Montréal
Aug 22, 2022

HIV Trial in Spain (Unique)

Completed
  • HIV
  • Santiago de Compostela, A Coruña, Spain
  • +23 more
Nov 11, 2019

Polycystic Ovary Syndrome, Hypertension Trial in New Haven (GnRH antagonist, GnRH antagonist + MethylTESTOSTERone 5 MG)

Completed
  • Polycystic Ovary Syndrome
  • Hypertension
  • GnRH antagonist
  • GnRH antagonist + MethylTESTOSTERone 5 MG
  • New Haven, Connecticut
    The John B Pierce Laboratory
Dec 8, 2022

in Vitro Fertilization, Poor Responder Trial in Toronto (metoclopramide)

Withdrawn
  • in Vitro Fertilization
  • Poor Responder
  • Toronto, Ontario, Canada
    Mount Sinai Hospital
Apr 7, 2022

Ovarian Stimulation Trial in Shibin Al Kawm (Letrozole 2.5mg tablet)

Recruiting
  • Ovarian Stimulation
  • Letrozole 2.5mg tablet
  • Shibīn Al Kawm, Menoufia, Egypt
    Menoufia University hospital
Dec 8, 2021

Adverse Effect Trial (normal saline, Ondansetron 4 mg, Ondansetron 8 mg)

Not yet recruiting
  • Adverse Effect
  • normal saline
  • +2 more
  • (no location specified)
Jul 25, 2022

HIV, Human Immunodeficiency Virus Trial in San Francisco (PRO 140 350mg weekly SQ injection.)

Completed
  • HIV
  • Human Immunodeficiency Virus
  • PRO 140 350mg weekly SQ injection.
  • San Francisco, California
    Quest Clinical Research
Sep 28, 2021

HIV, Human Immunodeficiency Virus Trial in San Francisco (PRO 140 350mg weekly SQ injection.)

Active, not recruiting
  • HIV
  • Human Immunodeficiency Virus
  • PRO 140 350mg weekly SQ injection.
  • San Francisco, California
    CD01-Extension Investigational Site
Sep 28, 2021

Metastatic Castration Resistant Prostate Cancer Trial in Switzerland, United Kingdom (AZD5069, Enzalutamide 40 MG)

Active, not recruiting
  • Metastatic Castration Resistant Prostate Cancer
  • Bellinzona, Switzerland
  • +3 more
Mar 18, 2022

Cord Blood Transplantation With CCR5?32 Donor Cells on HIV

Active, not recruiting
  • HIV Infection
    • New York, New York
      Weill Cornell Uptown Clinical Research Site (7803)
    Feb 3, 2022